MDS Pharma Services has appointed Todd Johnson to be senior vice president of strategy and corporate development.
Johnson previously was a strategic consultant for pharmaceutical and biotechnology companies at McKinsey & Company. He also was CEO of Tangerine Technologies and was a cancer researcher at Harvard’s Dana-Farber Cancer Institute, the University of Pennsylvania, and at the National Institutes of Health.
Beckman Coulter said this week that Risa Lavizzo-Mourey has resigned from the company’s board of directors, effective June 1. She is currently president and CEO of the Robert Wood Johnson Foundation. Beckman said it is conducting a search for candidates to replace Lavizzo-Mourey.
Belgian biomarker company Pronota has appointed John Berriman chairman. Berriman was chairman of Algeta and is a director at MicroMet, Ablynx, and Oxxon Therapeutics.
He had been a director at Abingworth Management, worked at Celltech Group and Celltech Therapeutics, and founded Celltech Biologics. Berriman also was a director and co-founder at Solexa, chairman of Chroma Therapeutics, and was a director at Epigenomics, Alnylam, and XCounter.